×
Log in
Upload File
Most Popular
Art & Photos
Automotive
Business
Career
Design
Education
Hi-Tech
+ Browse for More
The top documents tagged [pediatric exclusivity]
Documents
Patent Term Extension Strategies in the Pharmaceutical Industry
35 views
Documents
Drug development and regulation
1.811 views
Health & Medicine
Health Care lecture - Changing Your Child's Future
190 views
Healthcare
Global Anxiety Disorders Market 2015-2019
156 views
Documents
1 One Year Post Exclusivity Adverse Event Review ADDERALL XR ® Pediatric Advisory Committee Meeting March 22, 2006 Susan K. McCune, M.D. Medical Officer
214 views
Documents
Direct-to-Consumer Advertising: A Dangerous Game of Pitching Products to Parents Lynne Wells Graziano Department of History Case Western Reserve University
214 views
Documents
A New Pathway for Follow-on Biologics Presented by: Steve Nash
[email protected]
May 7, 2010
215 views
Documents
© 2009 Pharmaceutical Law Group PC Market Exclusivity Paradigm Gregory J. Glover, MD, JD Pharmaceutical Law Group
[email protected]
217 views
Documents
1 One Year Post-Exclusivity Adverse Event Review for Tamiflu® (oseltamivir) Pediatric Advisory Committee Meeting November 18, 2005 Melissa M. Truffa, R.Ph
217 views
Documents
1 One Year Post Exclusivity Adverse Event Review as Mandated by the Best Pharmaceuticals for Children Act Presented at the Psychopharmacologic Drugs Advisory
215 views
Documents
1 One Year Post Exclusivity Adverse Event Review: Topotecan Pediatric Subcommittee of the Anti-infective Drugs Advisory Committee Meeting June 9, 2004
215 views